Wnt5a Signaling in Normal and Cancer Stem Cells

被引:21
|
作者
Zhou, Yan [1 ]
Kipps, Thomas J. [1 ,2 ]
Zhang, Suping [1 ,2 ]
机构
[1] Shenzhen Univ, Sch Med, Med Canc Res Ctr, Shenzhen 518060, Peoples R China
[2] Univ Calif San Diego, Moores UCSD Canc Ctr, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA
基金
中国国家自然科学基金;
关键词
EPITHELIAL OVARIAN-CANCER; MAMMARY-GLAND DEVELOPMENT; MESENCHYMAL TRANSITION; SELF-RENEWAL; TRANSGENIC MICE; BREAST-CANCER; PATHWAY; RECEPTOR; TUMOR; GENE;
D O I
10.1155/2017/5295286
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Wnt5a is involved in activating several noncanonical Wnt signaling pathways, which can inhibit or activate canonical Wnt/beta-catenin signaling pathway in a receptor context-dependent manner. Wnt5a signaling is critical for regulating normal developmental processes, including stem cell self-renewal, proliferation, differentiation, migration, adhesion, and polarity. Moreover, the aberrant activation or inhibition of Wnt5a signaling is emerging as an important event in cancer progression, exerting both oncogenic and tumor suppressive effects. Recent studies show the involvement of Wnt5a signaling in regulating normal and cancer stem cell self-renewal, cancer cell proliferation, migration, and invasion. In this article, we review recent findings regarding the molecular mechanisms and roles of Wnt5a signaling in stem cells in embryogenesis and in the normal or neoplastic breast or ovary, highlighting that Wnt5a may have different effects on target cells depending on the surface receptors expressed by the target cell.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
    H Yamamoto
    N Oue
    A Sato
    Y Hasegawa
    H Yamamoto
    A Matsubara
    W Yasui
    A Kikuchi
    Oncogene, 2010, 29 : 2036 - 2046
  • [32] Blockade of Wnt5A/ROR1 signaling as cancer stem cell targeting therapy for metastatic prostate cancer
    Jamieson, Christina A. M.
    Murtadha, Jamillah
    Oh, Christopher S.
    Muldong, Michelle T.
    Etemadfard, Niloofar
    Koutouan, Evodie
    Yoon, Young E.
    Lee, Sanghee
    Kwon, Oh
    Oh, Jong J.
    Kim, Min S.
    Willert, Karl
    Cacalano, Nicholas A.
    Jamieson, Catriona H. M.
    Gaasterland, Terry
    Mckay, Rana R.
    Kane, Christopher J.
    Kulidjian, Anna A.
    Prussak, Charles E.
    CANCER RESEARCH, 2024, 84 (06)
  • [33] Wnt5a Supports Osteogenic Lineage Decisions in Embryonic Stem Cells
    Keller, Kevin C.
    Ding, Huawen
    Tieu, Rudy
    Sparks, Nicole R. L.
    Ehnes, Devon D.
    Nieden, Nicole I. Zur
    STEM CELLS AND DEVELOPMENT, 2016, 25 (13) : 1020 - 1032
  • [34] Wnt5a regulates dental follicle stem/progenitor cells of the periodontium
    Xiang L.
    Chen M.
    He L.
    Cai B.
    Du Y.
    Zhang X.
    Zhou C.
    Wang C.
    Mao J.J.
    Ling J.
    Stem Cell Research & Therapy, 5 (6)
  • [35] Enhanced dopaminergic differentiation of neural and embryonic stem cells by Wnt5a
    Arenas, Ernest
    Parish, Clare
    Liste, Isabel
    Ribeiro, Diogo
    Andersson, Emma
    Salto, Carmen
    Ramirez, Carmen
    Bryja, Vitezslav
    HUMAN GENE THERAPY, 2009, 20 (11) : 1368 - 1369
  • [36] Wnt signaling, stem cells, and cancer.
    Nusse, Roel
    CANCER RESEARCH, 2013, 73 (08)
  • [37] Wnt5a and its signaling pathway in angiogenesis
    Shi, Ya-Ning
    Zhu, Neng
    Liu, Chan
    Wu, Hong-Tao
    Gui, Yu
    Liao, Duan-Fang
    Qin, Li
    CLINICA CHIMICA ACTA, 2017, 471 : 263 - 269
  • [38] Wnt signaling in stem cells and lung cancer
    He, B.
    Jablons, D. M.
    CANCER STEM CELLS: NOVEL CONCEPTS AND PROSPECTS FOR TUMOR THERAPY, 2007, 5 : 27 - +
  • [39] Inhibition of Wnt signaling and cancer stem cells
    Lu, Desheng
    Carson, Dennis A.
    ONCOTARGET, 2011, 2 (08) : 587 - 587
  • [40] Wnt5a influences the directional displacement of ovarian cancer cells
    Grither, Whitney
    Morikis, Vasilios
    Baker, Breanna
    Hagemann, Andrea
    Khabele, Dineo
    Kuroki, Lindsay
    Mutch, David
    Powell, Matthew
    Thaker, Premal
    Fuh, Katherine
    Longmore, Gregory
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S337 - S337